ForecastedOpportunity CDC-RFA-DD-27-0028

Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge

Centers for Disease Control - NCBDDD · Department of Health and Human Services

At a glance

Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge is a forecasted federal cooperative agreement opportunity from the Centers for Disease Control - NCBDDD (Department of Health and Human Services). The agency's forecast estimates an application due date of April 26, 2027; forecast dates can change. Total estimated funding is $51M across about 23 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 93.073 (Birth Defects and Developmental Disabilities - Prevention and Surveillance).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Jul 24, 2026Forecast posted
Feb 25, 2027 (est.)Full notice expectednext date
Apr 26, 2027 (est.)Application deadline
Sep 1, 2027 (est.)Est. award date

Posted: Jul 24, 2026
Est. close date: Apr 26, 2027
Est. award date: Sep 1, 2027
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $51,000,000
Implied average award: $2,217,391 calculated
Expected awards: 23
Cost sharing: Not required
Funding instrument: Cooperative Agreement
Opportunity category: Discretionary
Fiscal year: FY2027

Typical awards for this program (SAM.gov listing for ALN 93.073, not this notice): Range is dependent upon funding availability and specific grant activities. Award amounts range from $20,000 to $2,000,000. Average: $150,000

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public colleges & universities
Federally recognized tribal governments
Public & Indian housing authorities
Native American tribal organizations
501(c)(3) nonprofits
Nonprofits without 501(c)(3) status
Private colleges & universities
For-profit organizations (not small businesses)
Small businesses
Others (see notice)
Unrestricted (any entity type)

Additional information on eligibility (from the notice)

The NOFO has three components: Component A, Component B, and Component C. Eligible applicants may apply for only one component. If an applicant submits multiple applications, all applications submitted by that applicant will be deemed non-responsive, and will not receive further review. In the "Descriptive Title of Applicant's Project" on the SF-424 form, applicants must identify the component and, as applicable, the strategies for which they are applying. Applicants that do not identify the applicable components and strategies on the SF-424 form will be deemed non-responsive and will not receive further review. Eligible applicants for Component A must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic-based surveillance. This authority or access must allow unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO. Eligible applicants must upload this documentation as a PDF to www.grants.gov under "Other Attachment Forms" using the attachment name "Legal Authority".CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review. Eligible applicants for Component B must demonstrate their ability and capacity to identify and reach one or more target populations, which include people with FASDs, their families, and/or their communities, as well as clinical and public health professionals, who serve patients or clients who could be impacted by FASDs, across the United States. Applicants must also demonstrate their ability to develop new communication materials and continually identify and update resources that could be applied to one or more target populations, as well as quantify metrics of impact. Applicant's history of outreach to these populations should include, but may not be limited to, evidence-based educational information, resources, and support.Eligible applicants for Component C must be able to demonstrate ability to provide informatics and technical support to Component A applicants supporting standardized data collection, quality assurance, and timely data submission.

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD-27-0028, Maternal Child Surveillance and Partnerships for Action, Results, and Knowledge. This NOFO will integrate maternal child health surveillance with national partnership activities to address key public health challenges including alcohol use during pregnancy, fetal alcohol spectrum disorders (FASDs), neonatal abstinence syndrome (NAS), and cytomegalovirus (CMV).

The NOFO will support entities with appropriate data authority and infrastructure to initiate, sustain, enhance, and/or expand clinical surveillance systems capturing data on pregnant women, infants, and/or children. Funding will prioritize improving data quality and enabling timely reporting and dissemination of evolving outcome data.

Funded entities participating in clinical surveillance will monitor prenatal exposures such as alcohol use and polysubstance use during pregnancy as well as conditions with significant public health impact such as FASDs, NAS, congenital CMV, and other outcomes. CDC will also fund entities with informatics expertise to provide technical assistance to funded entities conducting clinical surveillance, improve data quality, and support dissemination of data through visualizations. Furthermore, this clinical surveillance network could be leveraged to address emerging, reemerging, and persistent public health threats to pregnant women and infants.

In addition, this NOFO will invest in national partnership activities to prevent FASDs and improve early identification as well as support and care of affected infants and children. Activities may include serving as a national FASD resource; advancing evidence-based messaging; building clinical capacity through a holistic, lifespan approach; addressing regional, state, local, and/or tribal jurisdiction gaps; advancing coordination and translation of activities; and evaluating program strategies.

Together, these activities establish a combined framework that emphasizes data to action approaches that translate high quality surveillance data into prevention strategies, pathways to referral and support, and improved outcomes.

How to apply

0 of 8 done · progress saved in this browser

Read the full announcement (NOFO)Eligibility, evaluation criteria, page limits and required attachments are in the full notice on Grants.gov. Open ↗
Confirm eligibility and fitCheck your organization type above; no cost sharing is required.
Register (or renew) in SAM.gov and get a UEIFree. New registrations can take several weeks; registrations must be renewed every year. Open ↗
Set up Grants.gov accessCreate a Grants.gov account and make sure someone has the Authorized Organization Representative (AOR) role. Open ↗
Watch for the full noticeThe agency estimates posting it around February 25, 2027. Save this grant to track changes.
Prepare narrative, budget and attachmentsFollow the notice's format exactly — page limits and required forms are common reasons applications are rejected.
Ask the agency contact any questions earlyAmanda Akosa · kcq9@cdc.gov Open ↗
Submit before April 26, 2027Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. Submit a few days early and keep your Grants.gov confirmation and validation emails.

Assistance Listing

What is an ALN?

93.073Birth Defects and Developmental Disabilities - Prevention and SurveillanceProgram →

Reported obligations under ALN 93.073

Historical data · not a prediction

FY24

$60M

FY25

$66.8M

FY26

$66.8M est.

Source: SAM.gov Assistance Listing 93.073. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Amanda Akosa
kcq9@cdc.gov
404-718-3409

Quick answers

Is “Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge” open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around February 25, 2027. Forecast details and dates can change.

Who is eligible to apply for “Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge”?

Per the notice, total estimated program funding is $51,000,000 and the agency expects to make about 23 awards.

How do I apply for “Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity CDC-RFA-DD-27-0028), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedALN 93.073